点击微球时代，创领介入未来！
Background:Microvascularinvasion(MVI)isapowerfulpredictorofrecurrenceinpatientswhoundergoliverresectionforhepatocellularcarcinoma(HCC).Thisstudyaimedtoevaluatetheefficacyofpostoperativeadjuvanttransarterialchemoembolization(PA-TACE)inHCCpatientswithMVI,andfurtherselectpotentialpatientsbenefittingfromPA-TACE.
背景：微血管侵犯(MVI)是肝细胞癌(HCC)肝切除术后复发的一个强有力的预测因子。本研究旨在评价HCC合并MVI患者术后辅助经动脉化疗栓塞(PA-TACE)的疗效，并进一步筛选出可能受益于PA-TACE的患者。
Methods:PatientswhohadHCCwithMVIandunderwentliverresectionbetweenSeptemberandDecemberwereidentifiedforfurtheranalysis.Overallsurvival(OS)anddisease-freesurvival(DFS)were